Home › Wilms Tumor › Georgia › Atlanta
Wilms Tumor clinical trials in Atlanta, GA
5 studies for Wilms Tumor are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
RecruitingPhase 2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
RecruitingPhase 2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecruitingPhase 1/2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
RecruitingPhase 1/2
- Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
RecruitingPhase 2
- Children's Healthcare of Atlanta (Data Collection and Specimen Analysis), Atlanta
About Wilms Tumor
Wilms' Tumor (or Nephroblastoma) is a rare type of cancer that affects one or both kidneys. Find a list of symptoms and treatments associated
More about Wilms Tumor on MedlinePlus
Wilms Tumor trials in other cities
- Washington, DC7 studies
- Memphis, TN6 studies
- Chicago, IL4 studies
- Boston, MA4 studies
- Los Angeles, CA4 studies
- Mountain View, CA4 studies
- St. Louis, MO4 studies
- New York City, NY4 studies
- Cincinnati, OH4 studies
- Houston, TX4 studies
- Aurora, CO4 studies
- Minneapolis, MN4 studies
Other studies in Atlanta
- Cancer (all types)50 studies
- Non-Small Cell Lung Cancer46 studies
- Breast Cancer41 studies
- Multiple Myeloma41 studies
- Prostate Cancer32 studies
- Colorectal Cancer29 studies
- Lung Cancer29 studies
- Ovarian Cancer28 studies
- Acute Myeloid Leukemia28 studies
- Obesity27 studies
- Metastatic Cancer27 studies
- Heart Failure25 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.